Euro-Pharm selects PharmEng as private-label supplier

By Elaine Rigoli

Tampa, Fla., March 21 - PharmEng International, Inc. announced Tuesday that Keata Pharma Inc., PharmEng's wholly owned contract manufacturing subsidiary, has entered into a three-year supply agreement with Euro-Pharm International Canada, Inc. to provide commercial manufacturing and pharmaceutical development services to Euro-Pharm.

This contract is estimated to exceed C$1 million annually, according to a company news release.

Euro-Pharm has selected Keata as the contract or private-label manufacturer covering 10 products with an additional six products in negotiation, the release said.

"Our company regards this initial contract as a starting point for our relationship with Keata. With the successful delivery of these products, we are ready to move substantial additional business in their direction," Euro-Pharm president Nello Caltagirone said in the release.

PharmEng, located in Toronto, Ont., is a full-service consulting and contract manufacturing company that serves the pharmaceutical and biotechnology industries in North America and internationally.

Euro-Pharm, based in Montreal, Quebec, is a privately held Canadian pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.